ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Spectre Acquisition Corp
1.63
0.0000
成交量：
- -
成交額：
- -
市值：
2,245.10萬
市盈率：
-0.83
高：
1.63
開：
1.63
低：
1.63
收：
1.63
52周最高：
5.52
52周最低：
0.6500
股本：
1,377.36萬
流通股本：
413.60萬
量比：
- -
換手率：
- -
股息：
- -
股息率：
- -
每股收益(TTM):
-1.9700
每股收益(LYR):
-1.6655
淨資產收益率：
-36.97%
總資產收益率：
-28.97%
市淨率：
2.13
市盈率(LYR):
-0.98
資料載入中...
總覽
公司
新聞資訊
公告
2021/06/10
重要事件披露
8-K - Current report
2021/05/13
重要事件披露
8-K - Current report
2021/05/10
季度報告
10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/03
重要事件披露
8-K - Current report
2021/04/16
重要事件披露
8-K - Current report
2021/04/13
重要事件披露
8-K - Current report
2021/03/25
年度報告
10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/05
重要事件披露
8-K - Current report
2021/02/25
超過5%披露
SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/25
超過5%披露
SC 13D - General statement of acquisition of beneficial ownership
2021/02/18
重要事件披露
8-K - Current report
2021/02/17
超過5%披露
SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/16
超過5%披露
SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03
重要事件披露
8-K - Current report
2021/01/25
重要事件披露
8-K - Current report
2021/01/19
重要事件披露
8-K - Current report
2021/01/11
重要事件披露
8-K - Current report
2021/01/05
超過5%披露
SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/11/20
重要事件披露
8-K - Current report
2020/11/13
季度報告
10-Q - Quarterly report [Sections 13 or 15(d)]
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣0平台費、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SPEX/filings"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"SPEX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPEX\",,,,,undefined,":{"symbol":"SPEX","market":"US","secType":"STK","nameCN":"Spectre Acquisition Corp","latestPrice":1.63,"timestamp":1584043200000,"preClose":1.63,"halted":8,"volume":0,"delay":0,"changeRate":0,"floatShares":4136026,"shares":13773600,"eps":-1.97,"marketStatus":"盤後交易","change":0,"latestTime":"02-26 19:20:26 EST","open":1.63,"high":1.63,"low":1.63,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.97,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1772154000000},"marketStatusCode":4,"symbolChange":{"newSymbol":"AIKI","executeDate":"2020-03-13"},"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":1.63,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SPEX\",,,,,undefined,":{"symbol":"SPEX","floatShares":4136026,"roa":"-28.97%","roe":"-36.97%","lyrEps":-1.665494,"shares":13773600,"dividePrice":0,"high":1.63,"amplitude":0,"preClose":1.63,"low":1.63,"week52Low":0.65,"pbRate":"2.13","week52High":5.52,"institutionHeld":0.0903,"latestPrice":1.63,"eps":-1.97,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.97,"open":1.63},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SPEX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-02-01","symbol":"SPEX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1612155600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2020-11-10","symbol":"SPEX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1604984400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2020-05-14","symbol":"SPEX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1589428800000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2020-03-13","symbol":"SPEX","oldSymbol":"SPEX","newSymbol":"AIKI","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1584072000000},{"market":"US","date":"2020-02-03","symbol":"SPEX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1580706000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SPEX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SPEX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v3/notice/important/events/list\",params:#symbol:\"SPEX\",pageSize:20,pageCount:1,market:\"us\",,,undefined,":[{"items":[{"cdn_pdf":false,"hasAttachments":true,"id":"12883629","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021031800-SPEX","pdf_url":null,"pub_time":1623254400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/0001213900-21-031800-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AIKI 2021 LD MICRO INVITATIONAL XI PRESENTATION DECK, DATED JUNE 10, 2021","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ea142513ex99-1_aikido.htm","primary":true,"translateUrl":null,"linkName":"ea142513ex99-1_aikido.htm","type":"EX-99.1","id":"NTFILE3oo2mF76gv6eNi5y","market":"us","size":19266},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ea142513-8k_aikidopharma.htm","primary":false,"translateUrl":null,"linkName":"ea142513-8k_aikidopharma.htm","type":"8-K","id":"NTFILE5u8WsQGXEuaFRAD8","market":"us","size":29068},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILEEaaguf4zqvnSZaQr","market":"us","size":74902},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_002.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_002.jpg","type":"GRAPHIC","id":"NTFILEEEGb16VLahn44RkA","market":"us","size":181200},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_003.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_003.jpg","type":"GRAPHIC","id":"NTFILEDAkSeW2Ya2eCK5YA","market":"us","size":138834},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_004.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_004.jpg","type":"GRAPHIC","id":"NTFILEDq3eA5osx9xoreKF","market":"us","size":179332},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_005.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_005.jpg","type":"GRAPHIC","id":"NTFILEAeLZM8Fn2TSfdGKS","market":"us","size":217409},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_006.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_006.jpg","type":"GRAPHIC","id":"NTFILE65szotZqaUxHDvsh","market":"us","size":225046},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_007.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_007.jpg","type":"GRAPHIC","id":"NTFILE7yxMqkQU2wx3rneC","market":"us","size":156611},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_008.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_008.jpg","type":"GRAPHIC","id":"NTFILE9ZFv4evqs2hbJSde","market":"us","size":189506},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_009.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_009.jpg","type":"GRAPHIC","id":"NTFILE3Fu8yysFN6kfvikB","market":"us","size":224152},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_010.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_010.jpg","type":"GRAPHIC","id":"NTFILEBtvHCYutUhjvfSs1","market":"us","size":181544},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_011.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_011.jpg","type":"GRAPHIC","id":"NTFILEGqb9Ge58sM4F7sqt","market":"us","size":221810},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_012.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_012.jpg","type":"GRAPHIC","id":"NTFILE9WrVaR6htJTio85U","market":"us","size":193360},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_013.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_013.jpg","type":"GRAPHIC","id":"NTFILE3m31WrmUMTBMPXYW","market":"us","size":188517},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021031800/ex99-1_014.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_014.jpg","type":"GRAPHIC","id":"NTFILEBrBXnXQTPqP1x6qT","market":"us","size":71313}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-06-10 00:00","pubTimestamp":1623254400,"title_zh":"8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"項目8.01：其他項目；項目9.01：財務報表和證物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883624","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021025950-SPEX","pdf_url":null,"pub_time":1620835200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/0001213900-21-025950-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"BENZINGA GLOBAL SMALL CAP CONFERENCE PRESENTATION, DATED MAY 13, 2021","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ea140763ex99-1_aikidopharma.htm","primary":true,"translateUrl":null,"linkName":"ea140763ex99-1_aikidopharma.htm","type":"EX-99.1","id":"NTFILEvXazQCuxLLyWDsgr","market":"us","size":15316},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ea140763-8k_aikidopharma.htm","primary":false,"translateUrl":null,"linkName":"ea140763-8k_aikidopharma.htm","type":"8-K","id":"NTFILEDpASpEWEbV7AZbq6","market":"us","size":19340},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILE6DmmgsRd1vH2MgRX","market":"us","size":101978},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_002.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_002.jpg","type":"GRAPHIC","id":"NTFILE27JBAUL45Asd5zPJ","market":"us","size":251316},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_003.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_003.jpg","type":"GRAPHIC","id":"NTFILE7TYsZ32i4XgwKJHi","market":"us","size":200762},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_004.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_004.jpg","type":"GRAPHIC","id":"NTFILE9aSzqY1drfoKEUS5","market":"us","size":245231},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_005.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_005.jpg","type":"GRAPHIC","id":"NTFILE79Kyg4s6t7E4BCZk","market":"us","size":284116},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_006.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_006.jpg","type":"GRAPHIC","id":"NTFILE5ad1vp1SEH6Sx5Nk","market":"us","size":211274},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_007.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_007.jpg","type":"GRAPHIC","id":"NTFILEHy6DCwQJ2fdGaDVS","market":"us","size":260371},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_008.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_008.jpg","type":"GRAPHIC","id":"NTFILEDLokJ9R216UUrHP9","market":"us","size":249345},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_009.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_009.jpg","type":"GRAPHIC","id":"NTFILEAwGjkEQt4oogrTxQ","market":"us","size":304202},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_010.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_010.jpg","type":"GRAPHIC","id":"NTFILEAxCW9uqRtEAyYg3A","market":"us","size":260499},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025950/ex99-1_011.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_011.jpg","type":"GRAPHIC","id":"NTFILEBmQGYqXEFy4NjbED","market":"us","size":103852}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-05-13 00:00","pubTimestamp":1620835200,"title_zh":"8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"項目8.01：其他項目；項目9.01：財務報表和證物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"12883602","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021025331-SPEX","pdf_url":null,"pub_time":1620576000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"SPEX","title":"10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度報告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025331/0001213900-21-025331-index.htm","us_notice_code":"Form 10-Q","us_title_en":"10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":true,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"財務報告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"財務報告","earn_infos":[{"id":98436,"name":"Condensed Consolidated Balance Sheets","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025331/R2.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98437,"name":"Condensed Consolidated Balance Sheets (Parentheticals)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025331/R3.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98438,"name":"Condensed Consolidated Statements of Operations (Unaudited)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025331/R4.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98439,"name":"Condensed Consolidated Statements of Changes in Stockholders??? Equity","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025331/R5.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98440,"name":"Condensed Consolidated Statements of Changes in Stockholders??? Equity (Parentheticals)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025331/R6.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98441,"name":"Condensed Consolidated Statements of Cash Flows","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021025331/R7.htm","cdn_url":"","translation_url":"","translate_status":0}],"event_type":"important_notice","event_name":"季度報告","pubTime":"2021-05-10 00:00","pubTimestamp":1620576000,"title_zh":"10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"12883619","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021024121-SPEX","pdf_url":null,"pub_time":1619971200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021024121/0001213900-21-024121-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-05-03 00:00","pubTimestamp":1619971200,"title_zh":"8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"項目8.01：其他項目；項目9.01：財務報表和證物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883596","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021021934-SPEX","pdf_url":null,"pub_time":1618502400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021021934/0001213900-21-021934-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXCLUSIVE PATENT LICENSE AGREEMENT BY AND AMONG SILO PHARMA INC., A DELAWARE COR","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021021934/ea139554ex10-1_alkidipharm.htm","primary":true,"translateUrl":null,"linkName":"ea139554ex10-1_alkidipharm.htm","type":"EX-10.1","id":"NTFILE4rTMbUWpDsziDjSV","market":"us","size":111212},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021021934/ea139554-8k_alkidipharm.htm","primary":false,"translateUrl":null,"linkName":"ea139554-8k_alkidipharm.htm","type":"8-K","id":"NTFILE2hpS2YC9cdVn7BpQ","market":"us","size":23674},{"description":"AMENDMENT TO EXCLUSIVE PATENT LICENSE AGREEMENT, DATED APRIL 12, 2021.","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021021934/ea139554ex10-2_alkidipharm.htm","primary":false,"translateUrl":null,"linkName":"ea139554ex10-2_alkidipharm.htm","type":"EX-10.2","id":"NTFILEienE3zGfGP5SBtgT","market":"us","size":124955}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-04-16 00:00","pubTimestamp":1618502400,"title_zh":"8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01項：訂立重要最終協議；第5.02項：董事或某些高級職員離任；選舉董事；某些主席團成員的任命：某些主席團成員的補償安排；項目9.01：財務報表和證物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883599","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021021415-SPEX","pdf_url":null,"pub_time":1618243200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021021415/0001213900-21-021415-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 4.01: Changes in Registrant's Certifying Accountant;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"LETTER OF MARCUM LLP, TO THE SECURITIES AND EXCHANGE COMMISSION DATED APRIL 12,","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021021415/ea139404ex16-1_aikido.htm","primary":true,"translateUrl":null,"linkName":"ea139404ex16-1_aikido.htm","type":"EX-16.1","id":"NTFILEGeDZsQHK1dHwzkZH","market":"us","size":3189},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021021415/ea139404-8k_aikido.htm","primary":false,"translateUrl":null,"linkName":"ea139404-8k_aikido.htm","type":"8-K","id":"NTFILE8viVqbniPXcWyZL6","market":"us","size":21086}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-04-13 00:00","pubTimestamp":1618243200,"title_zh":"8-K - Current report","summary_en":"Item 4.01: Changes in Registrant's Certifying Accountant;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第4.01項：註冊人註冊會計師變更；項目9.01：財務報表和證物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883621","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021017738-SPEX","pdf_url":null,"pub_time":1616601600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"SPEX","title":"10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"年度報告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/0001213900-21-017738-index.htm","us_notice_code":"Form 10-K","us_title_en":"10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"ANNUAL REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/f10k2020_aikidopharma.htm","primary":true,"translateUrl":null,"linkName":"f10k2020_aikidopharma.htm","type":"10-K","id":"NTFILE7BeoeZnyytJVEWqj","market":"us","size":1018017},{"description":"LIST OF SUBSIDIARIES","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/f10k2020ex21-1_aikido.htm","primary":false,"translateUrl":null,"linkName":"f10k2020ex21-1_aikido.htm","type":"EX-21.1","id":"NTFILEDGoutwNn8rPeCrPy","market":"us","size":2637},{"description":"INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM'S CONSENT","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/f10k2020ex23-1_aikido.htm","primary":false,"translateUrl":null,"linkName":"f10k2020ex23-1_aikido.htm","type":"EX-23.1","id":"NTFILEAeQ654jz4Aah1j4u","market":"us","size":2073},{"description":"CERTIFICATION","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/f10k2020ex31-1_aikido.htm","primary":false,"translateUrl":null,"linkName":"f10k2020ex31-1_aikido.htm","type":"EX-31.1","id":"NTFILE6Yn81V1Axai3C7Mt","market":"us","size":14625},{"description":"CERTIFICATION","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/f10k2020ex32-1_aikido.htm","primary":false,"translateUrl":null,"linkName":"f10k2020ex32-1_aikido.htm","type":"EX-32.1","id":"NTFILE8QKjET1csJvVz72T","market":"us","size":7024},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/img_001.jpg","primary":false,"translateUrl":null,"linkName":"img_001.jpg","type":"GRAPHIC","id":"NTFILEELvyBjNhwzrmYMoz","market":"us","size":7209},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021017738/img_002.jpg","primary":false,"translateUrl":null,"linkName":"img_002.jpg","type":"GRAPHIC","id":"NTFILE5K6a19yGpZq6d1Z2","market":"us","size":9017}],"type_name":"財務報告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"財務報告","earn_infos":[],"event_type":"important_notice","event_name":"年度報告","pubTime":"2021-03-25 00:00","pubTimestamp":1616601600,"title_zh":"10-K - Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883630","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021013614-SPEX","pdf_url":null,"pub_time":1614873600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/0001213900-21-013614-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"INVESTOR PRESENTATION, DATED MARCH 2021","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ea137036ex99-1_aikidopharm.htm","primary":true,"translateUrl":null,"linkName":"ea137036ex99-1_aikidopharm.htm","type":"EX-99.1","id":"NTFILE4pij9WsJtM44esbd","market":"us","size":20791},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ea137036-8k_aikidopharm.htm","primary":false,"translateUrl":null,"linkName":"ea137036-8k_aikidopharm.htm","type":"8-K","id":"NTFILEDLLHFw31oiAsqxmB","market":"us","size":18837},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILE3qMAZntttuiFgLDF","market":"us","size":62678},{"description":"GRAPHIC","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_002.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_002.jpg","type":"GRAPHIC","id":"NTFILEDhZ5RZeuZ5ALWSXx","market":"us","size":120946},{"description":"GRAPHIC","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_003.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_003.jpg","type":"GRAPHIC","id":"NTFILEGJ63ZggoiHrgNhsG","market":"us","size":138569},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_004.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_004.jpg","type":"GRAPHIC","id":"NTFILE4cYx2QaYGwSScdRz","market":"us","size":167764},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_005.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_005.jpg","type":"GRAPHIC","id":"NTFILECbafdTb67tbKRds3","market":"us","size":149916},{"description":"GRAPHIC","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_006.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_006.jpg","type":"GRAPHIC","id":"NTFILEDyUBktFRG2dXu4Gt","market":"us","size":136336},{"description":"GRAPHIC","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_007.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_007.jpg","type":"GRAPHIC","id":"NTFILE3dUFr5z9NKhFGG6A","market":"us","size":185503},{"description":"GRAPHIC","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_008.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_008.jpg","type":"GRAPHIC","id":"NTFILE4H1gT3XmyM7u3xYT","market":"us","size":115928},{"description":"GRAPHIC","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_009.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_009.jpg","type":"GRAPHIC","id":"NTFILE9AT95imrnZfT1FuR","market":"us","size":164385},{"description":"GRAPHIC","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_010.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_010.jpg","type":"GRAPHIC","id":"NTFILE9oja1kLyFHGQcdfx","market":"us","size":158676},{"description":"GRAPHIC","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_011.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_011.jpg","type":"GRAPHIC","id":"NTFILEHA83cdn2qxrKUKdC","market":"us","size":146019},{"description":"GRAPHIC","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_012.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_012.jpg","type":"GRAPHIC","id":"NTFILEGaTcQpwEicj5iYFJ","market":"us","size":161590},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_013.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_013.jpg","type":"GRAPHIC","id":"NTFILE2K7BheZAGKmHNAT7","market":"us","size":106514},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_014.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_014.jpg","type":"GRAPHIC","id":"NTFILEDG3AC6Zmprn32ZrB","market":"us","size":160789},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021013614/ex99-1_015.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_015.jpg","type":"GRAPHIC","id":"NTFILE4qqYRSqCuu2tB4Px","market":"us","size":54726}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-03-05 00:00","pubTimestamp":1614873600,"title_zh":"8-K - Current report","summary_en":"Item 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第7.01項：條例FD披露；項目9.01：財務報表和證物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883613","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465921027944-SPEX","pdf_url":null,"pub_time":1614182400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G - Statement of acquisition of beneficial ownership by individuals","symbol":"SPEX","title":"SC 13G - Statement of acquisition of beneficial ownership by individuals","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000110465921027944/0001104659-21-027944-index.htm","us_notice_code":"Form SC 13G","us_title_en":"SC 13G - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SC 13G","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000110465921027944/tm217745d5_sc13g.htm","primary":true,"translateUrl":null,"linkName":"tm217745d5_sc13g.htm","type":"SC 13G","id":"NTFILEEfYjx4WYTo6d3kZi","market":"us","size":67296}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2021-02-25 00:00","pubTimestamp":1614182400,"title_zh":"SC 13G - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883601","market":"us","labels":[],"media":"sec.gov","original_id":"AN151316221000027-SPEX","pdf_url":null,"pub_time":1614182400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13D - General statement of acquisition of beneficial ownership","symbol":"SPEX","title":"SC 13D - General statement of acquisition of beneficial ownership","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000151316221000027/0001513162-21-000027-index.htm","us_notice_code":"Form SC 13D","us_title_en":"SC 13D - General statement of acquisition of beneficial ownership","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SCHEDULE 13D","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000151316221000027/sc_13d.htm","primary":true,"translateUrl":null,"linkName":"sc_13d.htm","type":"SC 13D","id":"NTFILEHEjxNVSwNYNG6b1J","market":"us","size":85177}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2021-02-25 00:00","pubTimestamp":1614182400,"title_zh":"SC 13D - General statement of acquisition of beneficial ownership","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883632","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021010360-SPEX","pdf_url":null,"pub_time":1613577600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/0001213900-21-010360-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"AMENDED AND RESTATED UNDERWRITING AGREEMENT BY AND BETWEEN THE COMPANY AND H.C.","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/ea135980ex1-1_aikidopharma.htm","primary":true,"translateUrl":null,"linkName":"ea135980ex1-1_aikidopharma.htm","type":"EX-1.1","id":"NTFILEDr3kKQEYhUd3aVU7","market":"us","size":210347},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/ea135980-8k_aikidopharma.htm","primary":false,"translateUrl":null,"linkName":"ea135980-8k_aikidopharma.htm","type":"8-K","id":"NTFILEG7p9a8ecT8ZsiKxf","market":"us","size":29618},{"description":"OPINION OF ELLENOFF GROSSMAN & SCHOLE LLP","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/ea135980ex5-1_aikidopharma.htm","primary":false,"translateUrl":null,"linkName":"ea135980ex5-1_aikidopharma.htm","type":"EX-5.1","id":"NTFILE5oFcRtLim85w66AM","market":"us","size":7284},{"description":"FORM OF UNDERWRITER'S WARRANT","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/ea135980ex10-1_aikidopharma.htm","primary":false,"translateUrl":null,"linkName":"ea135980ex10-1_aikidopharma.htm","type":"EX-10.1","id":"NTFILE2MXkatVHCfrFvBCs","market":"us","size":103814},{"description":"PRESS RELEASE DATED FEBRUARY 16, 2021","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/ea135980ex99-1_aikidopharma.htm","primary":false,"translateUrl":null,"linkName":"ea135980ex99-1_aikidopharma.htm","type":"EX-99.1","id":"NTFILEDT6QB6LSQ5dunAcg","market":"us","size":10750},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/ex5-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex5-1_001.jpg","type":"GRAPHIC","id":"NTFILEDiMeCrJjoixDgESE","market":"us","size":3760},{"description":"GRAPHIC","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021010360/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILEC8MuLQuyG6ixd1mc","market":"us","size":5296}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-02-18 00:00","pubTimestamp":1613577600,"title_zh":"8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01項：訂立重要最終協議；第3.02項：未登記出售權益性證券；項目8.01：其他項目；項目9.01：財務報表和證物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883616","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021009748-SPEX","pdf_url":null,"pub_time":1613491200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G - Statement of acquisition of beneficial ownership by individuals","symbol":"SPEX","title":"SC 13G - Statement of acquisition of beneficial ownership by individuals","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021009748/0001213900-21-009748-index.htm","us_notice_code":"Form SC 13G","us_title_en":"SC 13G - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"SCHEDULE 13G","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021009748/ea135498-13gaikido_hoththera.htm","primary":true,"translateUrl":null,"linkName":"ea135498-13gaikido_hoththera.htm","type":"SC 13G","id":"NTFILEYbWEbNH3kcPoRNsa","market":"us","size":47708}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2021-02-17 00:00","pubTimestamp":1613491200,"title_zh":"SC 13G - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"12883610","market":"us","labels":[],"media":"sec.gov","original_id":"AN110465921023188-SPEX","pdf_url":null,"pub_time":1613404800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","symbol":"SPEX","title":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000110465921023188/0001104659-21-023188-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2021-02-16 00:00","pubTimestamp":1613404800,"title_zh":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"12883612","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021006449-SPEX","pdf_url":null,"pub_time":1612281600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021006449/0001213900-21-006449-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-02-03 00:00","pubTimestamp":1612281600,"title_zh":"8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01項：訂立重要最終協議；項目8.01：其他項目；項目9.01：財務報表和證物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883623","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021004059-SPEX","pdf_url":null,"pub_time":1611504000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021004059/0001213900-21-004059-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE, DATED JANUARY 22, 2021","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021004059/ea133854ex99-1_aikidopharma.htm","primary":true,"translateUrl":null,"linkName":"ea133854ex99-1_aikidopharma.htm","type":"EX-99.1","id":"NTFILE8imYnRMsHP3c5QXX","market":"us","size":7776},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021004059/ea133854-8k_aikidopharma.htm","primary":false,"translateUrl":null,"linkName":"ea133854-8k_aikidopharma.htm","type":"8-K","id":"NTFILE5iMd3v3B3rHop5by","market":"us","size":20069},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021004059/ex99-1_001.jpg","primary":false,"translateUrl":null,"linkName":"ex99-1_001.jpg","type":"GRAPHIC","id":"NTFILEAPDcGCUW89Mdgo59","market":"us","size":10738}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-01-25 00:00","pubTimestamp":1611504000,"title_zh":"8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"項目8.01：其他項目；項目9.01：財務報表和證物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883607","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021002859-SPEX","pdf_url":null,"pub_time":1610985600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021002859/0001213900-21-002859-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"CURRENT REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390021002859/ea133558-8k_aikidopharma.htm","primary":true,"translateUrl":null,"linkName":"ea133558-8k_aikidopharma.htm","type":"8-K","id":"NTFILEB2sVx5zWHfA6XoXY","market":"us","size":26683}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-01-19 00:00","pubTimestamp":1610985600,"title_zh":"8-K - Current report","summary_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","summary_zh":"項目5.07：將事項提交證券持有人表決","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"12883595","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390021001460-SPEX","pdf_url":null,"pub_time":1610294400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390021001460/0001213900-21-001460-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2021-01-11 00:00","pubTimestamp":1610294400,"title_zh":"8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 3.02: Unregistered Sales of Equity Securities;\nItem 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01項：訂立重要最終協議；第3.02項：未登記出售權益性證券；第5.03項：修改公司章程或章程細則；會計年度的變化；項目9.01：財務報表和證物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":false,"id":"12883615","market":"us","labels":[],"media":"sec.gov","original_id":"AN153561021000028-SPEX","pdf_url":null,"pub_time":1609776000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","symbol":"SPEX","title":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","titleType":"超過5%披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000153561021000028/0001535610-21-000028-index.htm","us_notice_code":"Form SC 13G/A","us_title_en":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Beneficial Ownership Change","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"超過5%披露","pubTime":"2021-01-05 00:00","pubTimestamp":1609776000,"title_zh":"SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883625","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020038376-SPEX","pdf_url":null,"pub_time":1605801600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"8-K - Current report","symbol":"SPEX","title":"8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390020038376/0001213900-20-038376-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.07: Submission of Matters to a Vote of Security Holders;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"PRESS RELEASE","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390020038376/ea130276ex99-1_alkido.htm","primary":true,"translateUrl":null,"linkName":"ea130276ex99-1_alkido.htm","type":"EX-99.1","id":"NTFILEETiFdX9GjpuUCqvr","market":"us","size":19840},{"description":"CURRENT REPORT","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390020038376/ea130276-8k_alkido.htm","primary":false,"translateUrl":null,"linkName":"ea130276-8k_alkido.htm","type":"8-K","id":"NTFILEDu3qVxAAqqkjJQwb","market":"us","size":38995},{"description":"GRAPHIC","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390020038376/image_001.jpg","primary":false,"translateUrl":null,"linkName":"image_001.jpg","type":"GRAPHIC","id":"NTFILEGoFgALtso4AQUqPo","market":"us","size":6183}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2020-11-20 00:00","pubTimestamp":1605801600,"title_zh":"8-K - Current report","summary_en":"Item 5.07: Submission of Matters to a Vote of Security Holders;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"項目5.07：將事項提交證券持有人表決；項目9.01：財務報表和證物","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"12883614","market":"us","labels":[],"media":"sec.gov","original_id":"AN121390020036928-SPEX","pdf_url":null,"pub_time":1605196800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"SPEX","title":"10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度報告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/0001213900-20-036928-index.htm","us_notice_code":"Form 10-Q","us_title_en":"10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":true,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"QUARTERLY REPORT","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/f10q0920_aikidopharma.htm","primary":true,"translateUrl":null,"linkName":"f10q0920_aikidopharma.htm","type":"10-Q","id":"NTFILE6s7XjJmXFxE4cwSi","market":"us","size":469655},{"description":"CERTIFICATION","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/f10q0920ex31-1_aikido.htm","primary":false,"translateUrl":null,"linkName":"f10q0920ex31-1_aikido.htm","type":"EX-31.1","id":"NTFILEESjtaLima2zhzsog","market":"us","size":15931},{"description":"CERTIFICATION","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/f10q0920ex32-1_aikido.htm","primary":false,"translateUrl":null,"linkName":"f10q0920ex32-1_aikido.htm","type":"EX-32.1","id":"NTFILECsjdozcRnptbQdmf","market":"us","size":6973}],"type_name":"財務報告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"財務報告","earn_infos":[{"id":98442,"name":"Condensed Consolidated Balance Sheets (Unaudited)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/R2.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98443,"name":"Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/R3.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98444,"name":"Condensed Consolidated Statements of Operations (Unaudited)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/R4.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98445,"name":"Consolidated Statements of Changes in Stockholders' Equity (Unaudited)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/R5.htm","cdn_url":"","translation_url":"","translate_status":0},{"id":98446,"name":"Condensed Consolidated Statements of Cash Flows (Unaudited)","name_zh":null,"url":"https://www.sec.gov/Archives/edgar/data/12239/000121390020036928/R6.htm","cdn_url":"","translation_url":"","translate_status":0}],"event_type":"important_notice","event_name":"季度報告","pubTime":"2020-11-13 00:00","pubTimestamp":1605196800,"title_zh":"10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":149,"code":"91000000","status":"200"}]}}